ArticlePloS one2018

Benefit, risk and cost of new oral anticoagulants and warfarin in atrial fibrillation; A multicriteria decision analysis.

Jose Mendoza-Sanchez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.